Expert Interview

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Getting an OBGYN's perspective on the use of Perrigo's Opill (norgestrel) a nonprescription daily oral contraceptive in the contraceptive landscape

Ticker(s): PRGO

Who's the expert?

Institution: Yale School of Medicine

Obstetrics & Gynecology Specialist at Yale University
Served as Chairperson of the Obstetrics and Gynecology department at Milford Hospital and currently manages 10 patients monthly at risk for preeclampsia
Research interest in predictors for perinatal outcomes

Interview Goal

This conversation will center around getting an OBGYN's viewpoint on how Perrigo's Opill has changed the contraceptive landscape as the FDA approved first non-prescription daily oral contraceptive

Are You Interested In These Questions?

Yes! Sign me up for FREE
so I can learn more Yes.
LOGIN!

Click Here to Access
This Project

Slingshot Insights Explained

JOIN FOR FREE TODAY

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

Click Here to Access
This Project

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.